Drug General Information
Drug ID	D0OJ9P
Former ID	DNC011054
Drug Name	1-methyl-3-(phenylcarbamoyloxy)pyridinium bromide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[551218]
Structure		Download 2D MOL 3D MOL
Formula	C13H13BrN2O2
Canonical SMILES	C[N+]1=CC=CC(=C1)OC(=O)NC2=CC=CC=C2.[Br-]
InChI	1S/C13H12N2O2.BrH/c1-15-9-5-8-12(10-15)17-13(16)14-11-6-3-2-4-7-11;/h2-10H,1H3;1H
InChIKey	WZOIYVSATGAMMK-UHFFFAOYSA-N
PubChem Compound ID	49799303
Target and Pathway
Target(s)	Cholinesterase	Target Info	Inhibitor	[551218]
PANTHER Pathway	Muscarinic acetylcholine receptor 1 and 3 signaling pathway
	Muscarinic acetylcholine receptor 2 and 4 signaling pathway
	Nicotinic acetylcholine receptor signaling pathway
WikiPathways	Irinotecan Pathway
References
Ref 551218	Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. Bioorg Med Chem. 2010 Jul 1;18(13):4687-93. doi: 10.1016/j.bmc.2010.05.022. Epub 2010 May 12.
Ref 551218	Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. Bioorg Med Chem. 2010 Jul 1;18(13):4687-93. doi: 10.1016/j.bmc.2010.05.022. Epub 2010 May 12.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.